North American Vaccine Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : North American Vaccine

NVX 1.140

-16.2%

Jan 16 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Don W Stone who wrote (304)	2/19/1998 1:14:00 PM
From: Don W Stone	Read Replies (2) of 507

To all: If you happen to go to the Yahoo/Zacks site from time to time you will note that it now reflects an event that took place sometime last month. The analyst from Buckingham Research announced his retirement to the private sector. Note: None of the analyst have changed their position. Thus the "consensus" numbers that are presented there are now derived from the input of 3 Bulls(all"STRong Buys") and 1 Bear/Short(a Strong Sell).There is nothing in between. Anyone care to take a guess at the eps estimates for each? I'll tell you that there is a very wide range. From losing a lot of money to making a lot of money. It's "black or white". The "smart money", the institutions in this case, IMO, are just waiting for FDA approval of CERTIVA, and then they will be following closely how CERTIVA does in the marketplace. Obviously the institutions are expecting things to work out very well over the long term.. The price of NVX right now is certainly not tracking the '98 earnings estimates that are out there . What could happen over the next month or so just could make the estimates from Goldman, UBS and Montgomery look extremely conservative. First things first. We'll see. :-}

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next